ENDRA Life Sciences Income Statement (2016-2021) | NDRA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021
Revenue & cost
Revenue (Quarter) -0.23M0.52M0.06M0.29M0.01M0.01M
Cost of Revenue (Quarter) 0.00M0.01M0.02M0.01M0.00M0.01M0.12M0.00M0.26M0.06M0.09M0.10M-0.25M0.11M0.13M0.14M0.19M0.16M0.26M0.28M0.38M
Gross Profit (Quarter) 0.28M0.01M0.17M0.00M0.01M
Operating items
Amortization - Intangibles (Quarter) 0.38M0.35M0.73M1.63M0.23M0.00M
Research & Development (Quarter) 0.20M0.10M0.14M0.16M0.10M0.17M0.30M1.36M1.67M0.84M1.16M1.05M1.77M1.30M1.47M2.03M1.52M1.49M1.77M1.14M1.14M1.74M1.17M1.42M
Selling, General & Administrative (Quarter) 0.27M0.38M0.45M0.43M0.26M0.88M0.73M0.87M1.07M0.94M0.83M0.91M0.92M0.93M1.07M0.94M1.47M1.27M1.35M0.92M1.27M1.20M1.20M1.27M
Other Operating Expenses (Quarter) -0.10M0.01M0.02M0.01M0.00M0.01M0.05M0.07M0.11M0.04M0.36M0.04M0.06M0.09M0.10M0.17M0.11M0.13M0.14M0.19M0.16M0.26M0.28M0.38M
Operating Expenses (Quarter) 0.37M0.49M0.61M0.60M0.36M1.06M1.08M2.30M2.84M1.82M2.36M2.00M2.75M2.33M2.64M3.13M3.10M2.89M3.26M2.25M2.58M3.20M2.65M3.07M
Operating Income (Quarter) -0.37M-0.49M-0.61M-0.32M-0.36M-1.06M-0.91M-2.30M-2.84M-1.82M-2.36M-2.00M-2.75M-2.33M-2.64M-3.13M-3.10M-2.89M-3.26M-2.25M-2.58M-3.20M-2.65M-3.07M
EBIT (Quarter) -0.37M-0.49M-0.61M-0.32M-0.36M-1.06M-0.91M-2.30M-2.84M-1.82M-2.36M-2.00M-2.75M-2.33M-2.64M-3.13M-3.10M-2.89M-3.26M-2.25M-2.58M-3.20M-2.65M-3.07M
Non-operating items
Other Non Operating Income (Quarter) -0.01M-0.38M0.00M0.00M0.01M-0.02M-0.03M-0.02M-0.00M-0.01M-0.04M-0.05M0.01M-0.00M0.31M-0.01M-0.35M
Non Operating Income (Quarter) -0.01M0.23M0.37M0.38M-0.38M0.37M0.00M0.00M0.01M-0.02M-0.40M0.37M-0.00M-0.01M-0.77M0.68M0.01M-0.00M-0.00M-0.01M0.31M0.00M-0.01M-0.34M
Net income details
EBT (Quarter) -0.38M-0.73M-0.98M-0.69M-0.74M-1.43M-0.91M-2.29M-2.83M-1.85M-2.76M-2.37M-2.75M-2.33M-3.41M-4.81M-3.32M-2.89M-3.26M-2.25M-2.27M-3.20M-2.66M-3.10M
Profit After Tax (Quarter) -0.38M-0.73M-0.98M-0.69M-0.74M-1.43M-0.91M-2.29M-2.83M-1.85M-2.76M-2.37M-2.75M-2.33M-3.41M-4.81M-3.32M-2.89M-3.26M-2.25M-2.27M-3.20M-2.66M-3.10M
Income from Continuing Operations (Quarter) -0.38M-0.73M-0.98M-0.69M-0.74M-1.43M-0.91M-2.29M-2.83M-1.85M-2.76M-2.37M-2.75M-2.33M-3.41M-4.81M-3.32M-2.89M-3.26M-2.25M-2.27M-3.20M-2.66M-3.10M
Consolidated Net Income (Quarter) -0.38M-0.73M-0.98M-0.69M-0.74M-1.43M-0.91M-2.29M-2.83M-1.85M-2.76M-2.37M-2.75M-2.33M-3.41M-4.81M-3.32M-2.89M-3.26M-2.25M-2.27M-3.20M-2.66M-3.10M
Income towards Parent Company (Quarter) -0.38M-0.73M-0.98M-0.69M-0.74M-1.43M-0.91M-2.29M-2.83M-1.85M-2.76M-2.37M-2.75M-2.33M-3.41M-4.81M-3.32M-2.89M-3.26M-2.25M-2.27M-3.20M-2.66M-3.10M
Preferred Dividend Payments (Quarter) -0.03M0.40M
Net Income towards Common Stockholders (Quarter) -0.38M-0.73M-0.98M-0.69M-0.74M-1.43M-0.91M-2.29M-2.83M-1.85M-2.76M-2.37M-2.75M-2.33M-3.41M-9.03M-3.32M-2.89M-3.65M-2.25M-2.39M-3.20M-2.66M-3.10M
Additional items
EPS (Basic) (Quarter) -0.52-1.01-1.35-0.96-1.03-0.59-0.23-0.65-0.72-0.47-0.70-0.28-0.37-0.31-0.46-1.20-0.29-0.20-0.15-0.22-0.06-0.08-0.06-5.35
Shares Outstanding (Weighted Average) (Quarter) 0.72M0.72M0.72M0.72M0.72M2.44M2.37M2.76M3.92M3.92M3.93M4.50M7.42M7.42M7.42M7.50M11.51M14.74M23.89M19.19M37.77M41.68M40.47M
EBITDA (Quarter) -0.37M-0.49M-0.61M-0.32M-0.36M-1.06M-0.91M-2.30M-2.84M-1.82M-2.36M-2.00M-2.75M-2.33M-2.64M-3.13M-3.10M-2.89M-3.26M-2.25M-2.58M-3.20M-2.65M-3.07M
Interest Expenses (Quarter) 0.23M0.37M0.37M0.00M